Search
| Leader | 00000nz a2200037n 45 0 | ||
|---|---|---|---|
| 001 | WKP|Q92666765 (VIAF cluster) (Authority/Source Record) | ||
| 003 | WKP | ||
| 005 | 20241121000335.0 | ||
| 008 | 241121nneanz||abbn n and d | ||
| 035 | ‡a (WKP)Q92666765 | ||
| 024 | ‡a 0000-0002-8308-5630 ‡2 orcid | ||
| 035 | ‡a (OCoLC)Q92666765 | ||
| 100 | 0 | ‡a Carolina Marques ‡c researcher (ORCID 0000-0002-8308-5630) ‡9 en | |
| 400 | 0 | ‡a Carolina Marques ‡c wetenschapper ‡9 nl | |
| 670 | ‡a Author's LIF regulates CXCL9 in tumor-associated macrophages and prevents CD8+ T cell tumor-infiltration impairing anti-PD1 therapy | ||
| 909 | ‡a (orcid) 0000000283085630 ‡9 1 | ||
| 919 | ‡a lifregulatescxcl9intumorassociatedmacrophagesandpreventscd8+tcelltumorinfiltrationimpairingantipd1therapy ‡A LIF regulates CXCL9 in tumor-associated macrophages and prevents CD8+ T cell tumor-infiltration impairing anti-PD1 therapy ‡9 1 | ||
| 996 | ‡2 PTBNP|1763968 | ||
| 996 | ‡2 LC|no2015103404 | ||
| 996 | ‡2 NTA|436965577 | ||
| 996 | ‡2 SUDOC|23292077X | ||
| 996 | ‡2 PTBNP|1890533 | ||
| 996 | ‡2 PTBNP|251076 | ||
| 996 | ‡2 PTBNP|1865446 | ||
| 996 | ‡2 RERO|A024072659 | ||
| 996 | ‡2 BLBNB|001441632 | ||
| 996 | ‡2 SUDOC|074264036 | ||
| 996 | ‡2 LC|nb2015000449 | ||
| 996 | ‡2 NUKAT|n 2015094897 | ||
| 996 | ‡2 DNB|130495409 | ||
| 996 | ‡2 ISNI|0000000070506390 | ||
| 996 | ‡2 ISNI|0000000066651800 | ||
| 996 | ‡2 BNE|XX5807845 | ||
| 996 | ‡2 ISNI|000000000100301X | ||
| 996 | ‡2 LC|n 86853770 | ||
| 996 | ‡2 DNB|1127872338 | ||
| 996 | ‡2 ISNI|0000000444377010 | ||
| 996 | ‡2 RERO|A018711268 | ||
| 996 | ‡2 ISNI|0000000068408062 | ||
| 996 | ‡2 PTBNP|1233880 | ||
| 996 | ‡2 BNF|16010393 | ||
| 996 | ‡2 PTBNP|1656746 | ||
| 997 | ‡a 0 0 lived 0 0 ‡9 1 |
